Global Longevity and Anti-senescence Therapy Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Longevity and Anti-senescence Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hemolytic Drug Therapy
1.4.3 Gene Therapy
1.4.4 Immunotherapy
1.4.5 Other Stem Cell Therapies
1.5 Market by Application
1.5.1 Global Longevity and Anti-senescence Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Medical Service Institution
1.5.4 Drug and Device Sales
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Longevity and Anti-senescence Therapy Market Perspective (2015-2026)
2.2 Longevity and Anti-senescence Therapy Growth Trends by Regions
2.2.1 Longevity and Anti-senescence Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Longevity and Anti-senescence Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Longevity and Anti-senescence Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Longevity and Anti-senescence Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Longevity and Anti-senescence Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Longevity and Anti-senescence Therapy Players by Market Size
3.1.1 Global Top Longevity and Anti-senescence Therapy Players by Revenue (2015-2020)
3.1.2 Global Longevity and Anti-senescence Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Longevity and Anti-senescence Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Longevity and Anti-senescence Therapy Market Concentration Ratio
3.2.1 Global Longevity and Anti-senescence Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Longevity and Anti-senescence Therapy Revenue in 2019
3.3 Longevity and Anti-senescence Therapy Key Players Head office and Area Served
3.4 Key Players Longevity and Anti-senescence Therapy Product Solution and Service
3.5 Date of Enter into Longevity and Anti-senescence Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Longevity and Anti-senescence Therapy Historic Market Size by Type (2015-2020)
4.2 Global Longevity and Anti-senescence Therapy Forecasted Market Size by Type (2021-2026)
5 Longevity and Anti-senescence Therapy Breakdown Data by Application (2015-2026)
5.1 Global Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)
5.2 Global Longevity and Anti-senescence Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Longevity and Anti-senescence Therapy Market Size (2015-2020)
6.2 Longevity and Anti-senescence Therapy Key Players in North America (2019-2020)
6.3 North America Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
6.4 North America Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Longevity and Anti-senescence Therapy Market Size (2015-2020)
7.2 Longevity and Anti-senescence Therapy Key Players in Europe (2019-2020)
7.3 Europe Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
7.4 Europe Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)
8 China
8.1 China Longevity and Anti-senescence Therapy Market Size (2015-2020)
8.2 Longevity and Anti-senescence Therapy Key Players in China (2019-2020)
8.3 China Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
8.4 China Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Longevity and Anti-senescence Therapy Market Size (2015-2020)
9.2 Longevity and Anti-senescence Therapy Key Players in Japan (2019-2020)
9.3 Japan Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
9.4 Japan Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Longevity and Anti-senescence Therapy Market Size (2015-2020)
10.2 Longevity and Anti-senescence Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)
11 India
11.1 India Longevity and Anti-senescence Therapy Market Size (2015-2020)
11.2 Longevity and Anti-senescence Therapy Key Players in India (2019-2020)
11.3 India Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
11.4 India Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Longevity and Anti-senescence Therapy Market Size (2015-2020)
12.2 Longevity and Anti-senescence Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Longevity and Anti-senescence Therapy Market Size by Type (2015-2020)
12.4 Central & South America Longevity and Anti-senescence Therapy Market Size by Application (2015-2020)
13Key Players Profiles
13.1 CohBar
13.1.1 CohBar Company Details
13.1.2 CohBar Business Overview and Its Total Revenue
13.1.3 CohBar Longevity and Anti-senescence Therapy Introduction
13.1.4 CohBar Revenue in Longevity and Anti-senescence Therapy Business (2015-2020))
13.1.5 CohBar Recent Development
13.2 TA Sciences
13.2.1 TA Sciences Company Details
13.2.2 TA Sciences Business Overview and Its Total Revenue
13.2.3 TA Sciences Longevity and Anti-senescence Therapy Introduction
13.2.4 TA Sciences Revenue in Longevity and Anti-senescence Therapy Business (2015-2020)
13.2.5 TA Sciences Recent Development
13.3 Unity Biotechnology
13.3.1 Unity Biotechnology Company Details
13.3.2 Unity Biotechnology Business Overview and Its Total Revenue
13.3.3 Unity Biotechnology Longevity and Anti-senescence Therapy Introduction
13.3.4 Unity Biotechnology Revenue in Longevity and Anti-senescence Therapy Business (2015-2020)
13.3.5 Unity Biotechnology Recent Development
13.4 AgeX Therapeutics,Inc
13.4.1 AgeX Therapeutics,Inc Company Details
13.4.2 AgeX Therapeutics,Inc Business Overview and Its Total Revenue
13.4.3 AgeX Therapeutics,Inc Longevity and Anti-senescence Therapy Introduction
13.4.4 AgeX Therapeutics,Inc Revenue in Longevity and Anti-senescence Therapy Business (2015-2020)
13.4.5 AgeX Therapeutics,Inc Recent Development
13.5 PowerVision Inc.
13.5.1 PowerVision Inc. Company Details
13.5.2 PowerVision Inc. Business Overview and Its Total Revenue
13.5.3 PowerVision Inc. Longevity and Anti-senescence Therapy Introduction
13.5.4 PowerVision Inc. Revenue in Longevity and Anti-senescence Therapy Business (2015-2020)
13.5.5 PowerVision Inc. Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Longevity and Anti-senescence Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Longevity and Anti-senescence Therapy Revenue
Table 3. Ranking of Global Top Longevity and Anti-senescence Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Longevity and Anti-senescence Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hemolytic Drug Therapy
Table 6. Key Players of Gene Therapy
Table 7. Key Players of Immunotherapy
Table 8. Key Players of Other Stem Cell Therapies
Table 9. Global Longevity and Anti-senescence Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Longevity and Anti-senescence Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Longevity and Anti-senescence Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Longevity and Anti-senescence Therapy Market Share by Regions (2015-2020)
Table 13. Global Longevity and Anti-senescence Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Longevity and Anti-senescence Therapy Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Longevity and Anti-senescence Therapy Market Growth Strategy
Table 19. Main Points Interviewed from Key Longevity and Anti-senescence Therapy Players
Table 20. Global Longevity and Anti-senescence Therapy Revenue by Players (2015-2020) (Million US$)
Table 21. Global Longevity and Anti-senescence Therapy Market Share by Players (2015-2020)
Table 22. Global Top Longevity and Anti-senescence Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Longevity and Anti-senescence Therapy as of 2019)
Table 23. Global Longevity and Anti-senescence Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Longevity and Anti-senescence Therapy Product Solution and Service
Table 26. Date of Enter into Longevity and Anti-senescence Therapy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 29. Global Longevity and Anti-senescence Therapy Market Size Share by Type (2015-2020)
Table 30. Global Longevity and Anti-senescence Therapy Revenue Market Share by Type (2021-2026)
Table 31. Global Longevity and Anti-senescence Therapy Market Size Share by Application (2015-2020)
Table 32. Global Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 33. Global Longevity and Anti-senescence Therapy Market Size Share by Application (2021-2026)
Table 34. North America Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 36. North America Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 37. North America Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 38. North America Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 39. North America Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 40. Europe Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 42. Europe Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 44. Europe Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 46. China Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 47. China Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 48. China Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 49. China Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 50. China Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 51. China Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 52. Japan Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 54. Japan Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 56. Japan Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 60. Southeast Asia Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 62. Southeast Asia Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 64. India Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 65. India Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 66. India Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 67. India Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 68. India Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 69. India Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Longevity and Anti-senescence Therapy Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Longevity and Anti-senescence Therapy Market Share (2019-2020)
Table 72. Central & South America Longevity and Anti-senescence Therapy Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Longevity and Anti-senescence Therapy Market Share by Type (2015-2020)
Table 74. Central & South America Longevity and Anti-senescence Therapy Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Longevity and Anti-senescence Therapy Market Share by Application (2015-2020)
Table 76. CohBar Company Details
Table 77. CohBar Business Overview
Table 78. CohBar Product
Table 79. CohBar Revenue in Longevity and Anti-senescence Therapy Business (2015-2020) (Million US$)
Table 80. CohBar Recent Development
Table 81. TA Sciences Company Details
Table 82. TA Sciences Business Overview
Table 83. TA Sciences Product
Table 84. TA Sciences Revenue in Longevity and Anti-senescence Therapy Business (2015-2020) (Million US$)
Table 85. TA Sciences Recent Development
Table 86. Unity Biotechnology Company Details
Table 87. Unity Biotechnology Business Overview
Table 88. Unity Biotechnology Product
Table 89. Unity Biotechnology Revenue in Longevity and Anti-senescence Therapy Business (2015-2020) (Million US$)
Table 90. Unity Biotechnology Recent Development
Table 91. AgeX Therapeutics,Inc Company Details
Table 92. AgeX Therapeutics,Inc Business Overview
Table 93. AgeX Therapeutics,Inc Product
Table 94. AgeX Therapeutics,Inc Revenue in Longevity and Anti-senescence Therapy Business (2015-2020) (Million US$)
Table 95. AgeX Therapeutics,Inc Recent Development
Table 96. PowerVision Inc. Company Details
Table 97. PowerVision Inc. Business Overview
Table 98. PowerVision Inc. Product
Table 99. PowerVision Inc. Revenue in Longevity and Anti-senescence Therapy Business (2015-2020) (Million US$)
Table 100. PowerVision Inc. Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Longevity and Anti-senescence Therapy Market Share by Type: 2020 VS 2026
Figure 2. Hemolytic Drug Therapy Features
Figure 3. Gene Therapy Features
Figure 4. Immunotherapy Features
Figure 5. Other Stem Cell Therapies Features
Figure 6. Global Longevity and Anti-senescence Therapy Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Medical Service Institution Case Studies
Figure 9. Drug and Device Sales Case Studies
Figure 10. Longevity and Anti-senescence Therapy Report Years Considered
Figure 11. Global Longevity and Anti-senescence Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Longevity and Anti-senescence Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Longevity and Anti-senescence Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Longevity and Anti-senescence Therapy Market Share by Players in 2019
Figure 16. Global Top Longevity and Anti-senescence Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Longevity and Anti-senescence Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Longevity and Anti-senescence Therapy Revenue in 2019
Figure 18. North America Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Longevity and Anti-senescence Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. CohBar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. CohBar Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2015-2020)
Figure 27. TA Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. TA Sciences Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2015-2020)
Figure 29. Unity Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Unity Biotechnology Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2015-2020)
Figure 31. AgeX Therapeutics,Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AgeX Therapeutics,Inc Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2015-2020)
Figure 33. PowerVision Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. PowerVision Inc. Revenue Growth Rate in Longevity and Anti-senescence Therapy Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed